Roche Holding's influenza treatment is called Xofluza. "Roche Influenza Treatment Approved by European Commission," at 0628 GMT, misstated the name of the treatment in one instance.
(END) Dow Jones Newswires
01-11-21 0140ET
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
250 CHF | +0.08% |
|
+2.67% | +2.25% |
Jun. 20 | Sarepta Therapeutics Gets Expanded US FDA Approval for Treatment of Duchenne Muscular Dystrophy; Shares Soar After Hours | MT |
Jun. 20 | ROCHE HOLDINGS AG : UBS reiterates its Neutral rating | ZD |
Roche Holding's influenza treatment is called Xofluza. "Roche Influenza Treatment Approved by European Commission," at 0628 GMT, misstated the name of the treatment in one instance.
(END) Dow Jones Newswires
01-11-21 0140ET
1st Jan change | Capi. | |
---|---|---|
+2.25% | 228B | |
+51.99% | 803B | |
-5.72% | 351B | |
+18.94% | 324B | |
+11.07% | 303B | |
+16.96% | 243B | |
+11.15% | 217B | |
+7.59% | 164B | |
-3.65% | 155B | |
-1.84% | 117B |